Diana Gulei

4.7k total citations · 3 hit papers
71 papers, 2.9k citations indexed

About

Diana Gulei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Diana Gulei has authored 71 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 22 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Diana Gulei's work include MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (13 papers) and Circular RNAs in diseases (12 papers). Diana Gulei is often cited by papers focused on MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (13 papers) and Circular RNAs in diseases (12 papers). Diana Gulei collaborates with scholars based in Romania, United States and Italy. Diana Gulei's co-authors include Ioana Berindan‐Neagoe, Lajos Ráduly, Cornelia Braicu, Atanas G. Atanasov, Alexandru Irimie, Călin Ionescu, Roxana Cojocneanu, Alexandru Tirpe, Carmen Crivii and Mihail Buse and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and Cellular and Molecular Life Sciences.

In The Last Decade

Diana Gulei

70 papers receiving 2.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer

2019 671 citations Cornelia Braicu, Rareş Drulă et al. Cancers profile →
Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes

2019 308 citations Alexandru Tirpe, Diana Gulei et al. International Journal of Molecular Sciences profile →
Therapeutic advances of targeting receptor tyrosine kinases in cancer

2024 80 citations Ciprian Tomuleasa, Adrian Bogdan Țigu et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diana Gulei Romania	28	1.8k	1.0k	504	249	245	71	2.9k
Yuanyuan Wang China	34	1.8k 1.0×	935 0.9×	551 1.1×	322 1.3×	458 1.9×	121	3.0k
Noushin Nabavi Canada	29	1.4k 0.8×	921 0.9×	339 0.7×	304 1.2×	214 0.9×	107	2.5k
Huihui Li China	29	1.8k 1.0×	1.1k 1.0×	847 1.7×	298 1.2×	344 1.4×	132	3.3k
Meng Xu China	33	2.1k 1.1×	1.2k 1.2×	408 0.8×	321 1.3×	329 1.3×	104	3.2k
Yongmei Song China	33	2.6k 1.4×	1.1k 1.1×	706 1.4×	333 1.3×	200 0.8×	125	3.6k
Zakaria Y. Abd Elmageed United States	31	1.6k 0.9×	824 0.8×	583 1.2×	335 1.3×	324 1.3×	94	2.9k
Rezvan Najafi Iran	27	1.3k 0.7×	680 0.7×	540 1.1×	222 0.9×	268 1.1×	122	2.7k
Yingjie Zhang China	38	2.6k 1.4×	730 0.7×	811 1.6×	213 0.9×	292 1.2×	194	4.1k
Youwei Zhang China	30	2.3k 1.3×	1.0k 1.0×	574 1.1×	293 1.2×	160 0.7×	87	3.1k
Shiming Tan China	25	1.8k 1.0×	1.1k 1.1×	610 1.2×	321 1.3×	516 2.1×	61	2.8k

Countries citing papers authored by Diana Gulei

Since Specialization

Citations

This map shows the geographic impact of Diana Gulei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Gulei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Gulei more than expected).

Fields of papers citing papers by Diana Gulei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Gulei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Gulei. The network helps show where Diana Gulei may publish in the future.

Co-authorship network of co-authors of Diana Gulei

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Gulei. A scholar is included among the top collaborators of Diana Gulei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Gulei. Diana Gulei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rivas, Javier De Las, Bogdan Fetică, Rui Bergantim, et al.. (2025). Challenges in the preclinical design and assessment of CAR-T cells. Frontiers in Immunology. 16. 1564998–1564998. 3 indexed citations

Țigu, Adrian Bogdan, Raluca Munteanu, Cristian Moldovan, et al.. (2024). Therapeutic advances in the targeting of ROR1 in hematological cancers. Cell Death Discovery. 10(1). 471–471. 3 indexed citations

Tomuleasa, Ciprian, Adrian Bogdan Țigu, Raluca Munteanu, et al.. (2024). Therapeutic advances of targeting receptor tyrosine kinases in cancer. Signal Transduction and Targeted Therapy. 9(1). 201–201. 80 indexed citations breakdown →

Munteanu, Raluca, et al.. (2023). Insights into the Human Microbiome and Its Connections with Prostate Cancer. Cancers. 15(9). 2539–2539. 9 indexed citations

Gulei, Diana, Rareş Drulă, Gabriel Ghiaur, et al.. (2023). The Tumor Suppressor Functions of Ubiquitin Ligase KPC1: From Cell-Cycle Control to NF-κB Regulator. Cancer Research. 83(11). 1762–1767. 10 indexed citations

Munteanu, Raluca, Ciprian Tomuleasa, Cristina Adela Iuga, Diana Gulei, & Tudor–Eliade Ciuleanu. (2023). Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective. Cancers. 15(22). 5394–5394. 7 indexed citations

Drulă, Rareş, Diana Gulei, Cristina Adela Iuga, et al.. (2022). Exploiting the ubiquitin system in myeloid malignancies. From basic research to drug discovery in MDS and AML. Blood Reviews. 56. 100971–100971. 10 indexed citations

Zimța, Alina‐Andreea, Cătălin Constantinescu, Diana Gulei, et al.. (2021). The Possible Non-Mutational Causes of FVIII Deficiency: Non-Coding RNAs and Acquired Hemophilia A. Frontiers in Medicine. 8. 654197–654197. 3 indexed citations

Zimța, Alina‐Andreea, Ólafur E. Sigurjónsson, Diana Gulei, & Ciprian Tomuleasa. (2020). The Malignant Role of Exosomes as Nanocarriers of Rare RNA Species. International Journal of Molecular Sciences. 21(16). 5866–5866. 23 indexed citations

10.

Tefas, Lucia Ruxandra, Ioan Tomuță, Cristian Moldovan, et al.. (2020). Development of a Curcumin-Loaded Polymeric Microparticulate Oral Drug Delivery System for Colon Targeting by Quality-by-Design Approach. Pharmaceutics. 12(11). 1027–1027. 19 indexed citations

11.

Moloudizargari, Milad, Mohammad Hossein Asghari, Seyed Fazel Nabavi, et al.. (2020). Targeting Hippo signaling pathway by phytochemicals in cancer therapy. Seminars in Cancer Biology. 80. 183–194. 21 indexed citations

12.

Jahanban‐Esfahlan, Rana, Khaled Seidi, Maryam Majidinia, et al.. (2019). Toll‐like receptors as novel therapeutic targets for herpes simplex virus infection. Reviews in Medical Virology. 29(4). e2048–e2048. 26 indexed citations

13.

Berindan‐Neagoe, Ioana, Azadeh Manayi, Kasi Pandima Devi, et al.. (2019). Targeting Hedgehog signaling pathway: Paving the road for cancer therapy. Pharmacological Research. 141. 466–480. 70 indexed citations

14.

Nabavi, Seyed Fazel, Seyed Fazel Nabavi, Antonio García‐Ríos, et al.. (2019). Novel therapeutic strategies for stroke: The role of autophagy. Critical Reviews in Clinical Laboratory Sciences. 56(3). 182–199. 48 indexed citations

15.

Tirpe, Alexandru, et al.. (2019). Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes. International Journal of Molecular Sciences. 20(24). 6140–6140. 308 indexed citations breakdown →

16.

Nabavi, Seyed Fazel, Atanas G. Atanasov, Haroon Khan, et al.. (2018). Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials. Cancer Letters. 434. 101–113. 35 indexed citations

17.

Cătană, Cristina-Sorina, Diana Gulei, & Ioana Berindan‐Neagoe. (2017). New insights into the role of non-coding RNAs as transcriptional targets of p53. 43–49. 1 indexed citations

18.

Gulei, Diana, Ioana Berindan‐Neagoe, & George A. Calin. (2017). MicroRNas: beating cancer with new powerful weapons. 50–56. 2 indexed citations

19.

Gulei, Diana, Nikolay Mehterov, Hui Ling, et al.. (2017). The “good-cop bad-cop” TGF-beta role in breast cancer modulated by non-coding RNAs. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(7). 1661–1675. 38 indexed citations

20.

Gulei, Diana, Nikolay Mehterov, Seyed Mohammad Nabavi, Atanas G. Atanasov, & Ioana Berindan‐Neagoe. (2017). Targeting ncRNAs by plant secondary metabolites: The ncRNAs game in the balance towards malignancy inhibition. Biotechnology Advances. 36(6). 1779–1799. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact